BCAS3 抗体 (C-Term)
Quick Overview for BCAS3 抗体 (C-Term) (ABIN7453844)
抗原
See all BCAS3 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
原理
- Rabbit anti-BCAS3 Antibody, Affinity Purified
-
预测反应
- Mouse
-
纯化方法
- Affinity Purified
-
免疫原
- between AA 870 and C-term
-
亚型
- IgG
-
-
-
-
应用备注
-
IHC: 1:100 - 1:500. Epitope retrieval with citrate buffer pH 6.0 or Tris-EDTA pH 9.0 is recommended for FFPE tissue sections.
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
限制
- 仅限研究用
-
-
-
浓度
- 200 μg/mL
-
缓冲液
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
有效期
- 12 months
-
-
- BCAS3 (Breast Carcinoma Amplified Sequence 3 (BCAS3))
-
别名
- BCAS3
-
背景
- Background: Breast cancer amplified sequence 3 (BCAS3) was identified as a gene overexpressed and amplified in breast cancer cell lines. BCAS3 expression has been shown to be regulated by estrogen receptor alpha (ER alpha) and its coregulator PELP1 (proline-, glutamic acid-, and leucine-rich protein 1). BCAS3 has also been demonstrated to act as a coactivator of ER alpha activity in breast cancer cells and associate with the histone acetyltransferase complex protein P/CAF (p300/CBP-associated factor).
-
基因ID
- 54828
-
UniProt
- Q9H6U6
抗原
-